background
fatal
human
respiratori
diseas
associ
influenza
subtyp
document
hong
kong
recent
vietnam
thailand
cambodia
previous
demonstr
patient
diseas
unusu
high
serum
level
interferongammainduc
furthermor
compar
human
influenza
viru
subtyp
virus
ahong
potent
induc
proinflammatori
cytokin
eg
tumor
necrosi
factora
chemokin
eg
primari
human
macrophag
vitro
suggest
cytokin
dysregul
may
play
role
pathogenesi
diseas
sinc
respiratori
epitheli
cell
primari
target
cell
replic
influenza
virus
pertin
investig
cytokin
induct
profil
virus
cell
use
quantit
rtpcr
elisa
compar
profil
cytokin
chemokin
gene
express
induc
virus
human
viru
human
primari
alveolar
bronchial
epitheli
cell
vitro
demonstr
comparison
human
virus
virus
potent
induc
interferon
beta
rant
regul
activ
normal
cell
express
secret
interleukin
primari
human
alveolar
bronchial
epitheli
cell
vitro
recent
virus
vietnam
appear
even
potent
induc
viru
subtyp
influenza
virus
potent
induc
proinflammatori
cytokin
chemokin
primari
human
respiratori
epitheli
cell
subtyp
viru
suggest
hyperinduct
cytokin
may
relev
pathogenesi
human
diseas
influenza
pandem
aris
genet
reassort
avian
human
influenza
virus
altern
direct
adapt
avian
influenza
virus
effici
humantohuman
transmiss
avian
influenza
subtyp
transmit
poultri
human
hong
kong
caus
fatal
human
respiratori
diseas
subsequ
reemerg
human
diseas
southern
china
vietnam
thailand
cambodia
rais
specter
new
influenza
pandem
humantohuman
transmiss
subtyp
influenza
viru
appear
ineffici
far
diseas
except
sever
affect
report
mortal
rate
rang
hong
kong
thailand
vietnam
reason
unusu
sever
human
diseas
remain
unclear
dissemin
outsid
respiratori
tract
demonstr
human
diseas
evid
recent
virus
may
occasion
dissemin
multipl
organ
contribut
unusu
diseas
manifest
meningoenceph
howev
patient
diseas
primari
viral
pneumonia
complic
syndrom
acut
respiratori
distress
multipl
organ
dysfunct
lymphopenia
haemophagocytosi
notabl
find
syndrom
acut
respiratori
distress
multipl
organ
dysfunct
well
haemophagocytosi
previous
associ
cytokin
dysregul
influenza
viru
infect
bloodmonocytederiv
murin
human
macrophag
porcin
alveolar
macrophag
shown
result
induct
proinflammatori
cytokin
furthermor
previous
demonstr
compar
human
influenza
virus
infect
virus
lead
hyperinduct
proinflammatori
cytokin
human
primari
macrophag
cultur
vitro
also
report
patient
diseas
unusu
high
serum
concentr
chemokin
interferongammainduc
mig
monokin
induc
interferon
therefor
hypothes
differenti
hyperinduct
cytokin
chemokin
may
contribut
unusu
sever
human
diseas
macrophag
key
sentinel
cell
immun
system
permiss
influenza
viru
replic
primari
target
cell
viru
respiratori
epitheli
cell
primat
experiment
infect
viru
type
ii
pneumocyt
alveolar
macrophag
found
contain
viral
antigen
viru
infect
alveolar
pneumocyt
also
demonstr
lung
patient
fatal
diseas
human
alveolar
epitheli
cell
vital
mainten
lung
function
pulmonari
airblood
barrier
addit
human
respiratori
epitheli
cell
respond
viral
infect
mount
cytokin
respons
contribut
innat
adapt
host
defens
furthermor
type
ii
pneumocyt
express
class
ii
major
histocompat
complex
mhc
molecul
vivo
express
class
ii
mhc
usual
limit
special
cell
immun
system
whose
role
present
foreign
antigen
helper
cell
express
molecul
alveolar
epitheli
cell
like
relev
adapt
immun
respons
therefor
import
studi
cytokin
respons
induc
infect
epitheli
cell
influenza
virus
includ
virus
human
influenza
virus
previous
report
induc
interleukin
interleukin
rant
regul
activ
normal
cell
express
secret
vitro
transform
bronchial
epitheli
cell
line
howev
physiolog
relev
find
transform
cell
line
uncertain
primari
alveolar
epitheli
cell
cultur
would
relev
model
compar
cytokin
profil
induc
virus
human
primari
type
ii
pneumocyt
bronchial
epitheli
cell
vitro
test
hypothesi
virus
differenti
hyperinduc
proinflammatori
cytokin
respiratori
epitheli
cell
primari
human
bronchial
epitheli
cell
nhbe
obtain
cambrex
bio
scienc
walkersvil
inc
maryland
usa
nhbe
cell
grown
accord
supplier
instruct
serumfre
hormon
supplement
bronchial
epitheli
growth
media
begm
includ
supplement
gl
bovin
pituitari
extract
gl
hydrocortison
mgl
human
recombin
epiderm
growth
factor
gl
epinephrin
gl
transferrin
gl
insulin
mgl
retino
acid
mgl
gl
gentamicin
mgl
amphotericin
b
cambrex
bio
scienc
walkersvil
inc
maryland
usa
medium
chang
daili
start
day
seed
cell
reach
confluenc
approxim
day
nearli
confluent
cell
subcultur
use
trypsinedta
cambrex
ratio
experi
carri
batch
cell
passag
cell
incub
humidifi
atmospher
co
liquidcov
condit
primari
human
alveolar
epitheli
cell
type
ii
pneumocyt
isol
human
nontumor
lung
tissu
obtain
patient
mean
age
yr
rang
yr
male
femal
undergo
lung
resect
grantham
hospit
hong
kong
research
protocol
approv
ethic
committe
univers
hong
kong
hospit
author
hong
kong
west
cluster
human
type
ii
pneumocyt
isol
use
modif
method
previous
describ
briefli
remov
visibl
bronchi
lung
tissu
chop
piec
mm
thick
use
tissu
chopper
wash
balanc
salt
solut
bss
mm
nacl
mm
kcl
mm
na
hpo
mm
hepe
mm
glucos
ph
min
three
time
partial
remov
macrophag
blood
cell
tissu
digest
use
combin
trypsin
gibco
brl
gaithersburg
md
usa
elastas
unitsml
worthington
biochem
corpor
lakewood
nj
usa
twice
min
shake
waterbath
partial
digest
tissu
minc
presenc
fetal
bovin
serum
fb
medium
dnase
unitsml
gibco
brl
gaithersburg
md
usa
cell
clump
dispers
repeatedli
pipet
cell
suspens
minut
filtrat
gauz
cell
strainer
ensur
singl
cell
suspens
cell
incub
mixtur
medium
small
airway
growth
medium
sagm
cambrex
bio
scienc
walkersvil
inc
maryland
usa
contain
fb
unitsml
dnase
tissuecultur
treat
plastic
petri
dish
humidifi
incub
co
hour
order
let
macrophag
attach
plastic
surfac
nonadher
cell
layer
discontinu
percol
densiti
gradient
densiti
gml
centrifug
g
min
cell
layer
interfac
two
gradient
collect
wash
four
time
bss
remov
percol
remov
remain
alveolar
macrophag
cell
suspens
incub
magnet
bead
coat
antibodi
room
temperatur
min
constant
mix
remov
bead
use
magnet
assess
cell
viabil
trypanblu
exclus
purifi
type
ii
pneumocyt
suspens
suspend
sagm
supplement
fb
unitsml
penicillin
streptomycin
plate
cell
densiti
cellscm
cell
maintain
humidifi
atmospher
co
liquidcov
condit
growth
medium
chang
daili
start
hour
plate
cell
stain
alkalin
phosphatas
human
type
ii
pneumocyt
identifi
stain
alkalin
phosphatas
freshli
isol
cell
spun
glass
slide
airdri
stain
min
room
temperatur
stain
prepar
dissolv
mg
naphthol
biphosph
sigma
dmso
dilut
ml
propanol
buffer
ph
sigma
contain
mg
fast
red
sigma
slide
wash
counterstain
methylen
green
sigma
second
mount
aqueou
medium
cell
fix
glutaraldehyd
electron
microscopi
scienc
washington
pa
usa
wash
three
time
phosphat
buffer
salin
serial
dehydr
aceton
tissu
postfix
osmium
tetroxid
embed
araldit
resin
polysci
inc
washington
ps
usa
semithin
section
cut
use
ultramicrotom
reichert
ultracut
leica
aktiengesellscharft
wien
australia
diamond
knife
stain
toluidin
blue
light
microscop
examin
ultrathin
section
nm
mount
copper
grid
electron
contrast
uranyl
acet
hour
electron
microscopi
scienc
lead
citrat
minut
electron
microscopi
scienc
washington
pa
usa
examin
transmiss
electron
microscop
em
fei
compani
hillsboro
oregon
usa
express
cell
surfac
antigen
measur
stain
purifi
type
ii
pneumocyt
optim
dilut
rabbit
antihuman
surfact
proteinc
spc
upstat
lake
placid
ny
usa
monoclon
antibodi
minut
follow
fluorescein
isothiocyan
fitcconjug
goat
antimous
igg
antibodi
sigma
minut
cell
prepar
also
stain
antibodi
specif
monocyt
macrophag
surfac
antigen
conjug
fitc
serotec
oxford
uk
cell
examin
flow
cytometri
facsscalibur
becton
dickinson
fitcstain
cell
detect
measur
green
light
emit
nm
channel
percentag
cell
express
epitheli
macrophag
maker
determin
human
type
ii
pneumocyt
bronchial
epitheli
cell
seed
cell
per
well
tissuecultur
plate
infect
multipl
infect
moi
two
unless
otherwis
indic
min
viru
adsorpt
viru
inoculum
remov
cell
wash
warm
cultur
medium
sagm
transmiss
electron
micrograph
human
type
ii
pneumocyt
cultur
vitro
lamellar
bodi
cytoplasm
demonstr
use
higher
magnif
b
bar
nm
respect
figur
transmiss
electron
micrograph
human
type
ii
pneumocyt
cultur
vitro
lamellar
bodi
cytoplasm
demonstr
use
higher
magnif
b
bar
nm
respect
cell
scrape
cultur
flask
fix
glutaraldehyd
embed
araldit
resin
primari
human
type
ii
pneumocyt
stain
antibodi
surfact
proteinc
shade
curv
control
antibodi
unshad
curv
confirm
ident
figur
primari
human
type
ii
pneumocyt
stain
antibodi
surfact
proteinc
shade
curv
control
antibodi
unshad
curv
confirm
ident
b
human
type
ii
pneumocyt
isol
stain
fitcconjug
antibodi
shade
curv
specif
macrophag
surfac
antigen
check
contamin
macrophag
type
ii
pneumocyt
bebm
bronchial
epitheli
cell
incub
medium
supplement
mgl
penicillin
mgl
streptomycin
mgl
nptosyllphenylalanin
chloromethyl
ketonetreatedtrypsin
sigma
st
loui
mo
usa
aliquot
cultur
supernat
collect
frozen
subsequ
viru
titrat
cytokin
analysi
supernat
titrat
mdck
cell
viral
titr
quantit
log
tcid
ml
rna
extract
cell
analysi
cytokin
gene
express
ten
hour
infect
replic
cell
monolay
fix
analyz
immunofluoresc
stain
specif
influenza
viru
nucleoprotein
dako
imagen
dako
diagnost
ltd
eli
uk
determin
proport
cell
infect
dnasetr
total
rna
isol
mean
rneasi
mini
kit
qiagen
hilden
germani
cdna
synthes
mrna
poli
dt
primer
superscript
ii
revers
transcriptas
life
technolog
rockvil
md
usa
quantifi
realtim
pcr
analysi
lightcycl
roch
mannheim
germani
mrna
interferon
beta
rant
tumor
necrosi
factor
tnf
alpha
quantit
use
realtim
rtpcr
oligonucleotid
primer
method
use
realtim
quantif
cytokin
viral
matrix
gene
housekeep
gene
product
mrna
describ
previous
concentr
rant
interleukin
interferon
beta
protein
primari
human
bronchial
alveolar
epitheli
cell
supernat
measur
specif
elisa
assay
r
system
minneapoli
mn
usa
sampl
cultur
supernat
irradi
ultraviolet
light
ultra
violet
cross
linker
min
inactiv
infecti
viru
elisa
assay
done
previou
experi
confirm
dose
ultraviolet
light
use
affect
cytokin
concentr
measur
elisa
data
shown
quantit
cytokin
chemokin
mrna
protein
express
profil
compar
use
oneway
anova
follow
bonferroni
multiplecomparison
test
differ
consid
signific
p
primari
human
type
ii
pneumocyt
yield
cellsg
lung
tissu
cell
puriti
demonstr
express
type
ii
pneumocyt
specif
marker
surfact
protein
c
spc
lack
monocytemacrophag
cell
surfac
antigen
fig
stain
alkalin
phosphatas
activ
contamin
cell
predominantli
fibroblast
monocytemacrophag
cell
less
cell
viabil
n
differ
age
sex
lung
donor
appar
effect
cell
isol
yield
perform
cell
cultur
isol
cell
spread
form
confluent
mon
olay
exhibit
protrud
nuclei
surround
thin
cytoplasm
extens
ident
cell
cultur
human
type
ii
pneumocyt
confirm
demonstr
presenc
lamellar
bodi
microvilli
thin
section
electron
microscopi
figur
previou
studi
demonstr
avian
influenza
virus
infect
human
airway
epitheli
cell
first
want
determin
whether
alveolar
epitheli
cell
constitut
resid
lung
infect
avian
human
influenza
virus
vitro
cell
infect
influenza
subtyp
moi
proport
cell
express
influenza
viru
protein
analyz
hour
postinfect
immunofluoresc
stain
use
antibodi
specif
viru
nucleoprotein
dako
imagen
dako
diagnost
ltd
eli
uk
similar
proport
type
ii
pneumocyt
infect
viru
evid
viral
antigen
nucleoprotein
figur
quantif
influenza
mgene
copi
hour
infect
cell
infect
virus
show
compar
result
hour
postinfect
figur
similarli
infecti
viral
yield
hour
postinfect
alveolar
epitheli
cell
infect
virus
significantli
differ
figur
investig
cytokin
induct
profil
induc
virus
primari
human
type
ii
pneumocyt
specif
also
want
determin
two
virus
differ
qualit
quantit
profil
cytokin
induc
mrna
sever
cytokin
chemokin
quantifi
use
quantit
rtpcr
hr
hr
postinfect
tabl
mrna
level
interferon
beta
rant
significantli
upregul
influenza
viru
compar
mock
infect
cell
gene
interferon
beta
highli
induc
detect
tnf
alpha
induct
epitheli
cell
data
shown
inactiv
viru
ultraviolet
irradi
prior
infect
alveolar
epitheli
cell
abolish
cytokin
induct
data
shown
suggest
viru
replic
requir
cytokin
induct
compar
human
influenza
viru
virus
differenti
upregul
transcript
interferon
beta
rant
significantli
higher
level
p
figur
differ
explain
differ
proport
cell
infect
indic
immunofluoresc
viral
antigen
differ
viru
titr
figur
furthermor
increas
multipl
infect
viru
signal
normal
housekeep
gene
express
ratio
mock
infect
cell
upregul
two
time
mock
infect
p
b
p
bonferroni
multiplecomparison
test
c
correspond
charact
symbol
shown
figur
broadli
two
pattern
kinet
cytokin
gene
transcript
cytokin
upregul
hr
postinfect
onward
includ
interferon
beta
wherea
rant
mrna
upregul
hr
postinfect
tabl
observ
remain
valid
whether
cytokin
mrna
express
data
analyz
without
normal
mrna
concentr
cytokin
chemokin
profil
induc
virus
primari
human
bronchial
epitheli
cell
similarli
investig
ident
cell
cultur
human
bronchial
epitheli
cell
confirm
thin
section
electron
microscopi
figur
overal
gene
express
profil
compar
seen
type
ii
pneumocyt
mgene
transcript
copi
number
figur
infecti
viral
yield
figur
bronchial
epitheli
cell
infect
virus
moi
compar
virus
differenti
upregul
transcript
interferon
beta
rant
significantli
higher
level
human
viru
p
rant
p
interferon
beta
figur
addit
two
virus
differenti
upregul
transcript
monocyt
chemotact
protein
significantli
higher
level
human
virus
p
none
virus
induc
tnf
alpha
cell
confirm
observ
differ
mrna
reflect
level
cytokin
chemokin
secret
concentr
rant
interleukin
interferonbeta
protein
measur
elisa
cultur
supernat
infect
bronchial
alveolar
epitheli
cell
amount
secret
bronchial
alveolar
epitheli
cell
infect
three
virus
hour
post
infect
significantli
higher
p
secret
cell
infect
viru
figur
hour
post
infect
level
induc
virus
compar
howev
hour
postinfect
recent
virus
appear
even
potent
induc
viru
p
figur
rant
protein
secret
bronchial
alveolar
epitheli
cell
respons
significantli
higher
induc
viru
although
level
rant
mrna
infect
cell
hour
post
infect
significantli
higher
infect
cell
rant
protein
secret
cell
hour
post
infect
increas
fold
p
signific
figur
fail
detect
interferonbeta
protein
secret
supernat
bronchial
alveolar
epitheli
cell
influenza
virus
infect
data
shown
note
limit
detect
interferonbeta
elisa
high
pgml
found
replic
effici
virus
similar
primari
human
alveolar
figur
bronchial
epitheli
cell
figur
influenza
viru
subtyp
induc
interferon
beta
rant
respons
cytokin
induct
cytokin
chemokin
gene
express
profil
influenzavirusinfect
human
type
ii
pneumocyt
quantit
rtpcr
depend
viral
replic
sinc
uvinactiv
viru
induc
effect
interestingli
found
virus
potent
induc
interferonbeta
rant
mrna
protein
human
viru
figur
thu
observ
differ
mrna
reflect
level
cytokin
chemokin
protein
secret
figur
result
gener
similar
except
level
rant
protein
type
ii
pneumocyt
significantli
elev
compar
viru
infect
cell
figur
although
mrna
level
figur
inabl
detect
interferonbeta
protein
experi
spite
mark
induct
mrna
probabl
relat
limit
sensit
interferon
beta
elisa
sensit
bioassay
interferonbeta
may
requir
purpos
type
ii
pneumocyt
use
experi
deriv
total
donor
set
experiment
data
base
result
least
three
separ
experi
three
donor
therefor
exclud
donor
specif
artifact
cial
sourc
come
one
donor
howev
sinc
result
cell
broadli
line
type
ii
pneumocyt
think
donor
specif
artifact
unlik
explain
result
obtain
final
result
also
compar
previou
observ
primari
human
monocyt
deriv
macrophag
except
contrast
macrophag
tnf
alpha
beta
induc
respiratori
epitheli
cell
virus
test
remain
determin
whether
virus
also
act
via
signal
primari
human
epitheli
cell
cytokin
chemokin
respons
vivo
result
autocrin
paracrin
interact
involv
mani
cell
type
chemokin
macrophag
chemoattract
mediat
inflammatori
respons
recruit
circul
leukocyt
inflam
tissu
previous
demonstr
upregul
primari
human
macrophag
sarscov
strong
induct
chemokin
lung
microenviron
might
explain
promin
macrophag
infiltr
observ
lung
patient
fatal
well
sar
rant
attract
monocyt
eosinophil
basophil
cell
select
cell
product
bronchial
epitheli
cell
contribut
infiltr
inflammatori
cell
airway
viral
infect
multifunct
cytokin
regul
immun
inflammatori
respons
involv
activ
growth
differenti
tcell
contribut
cell
mediat
inflammatori
reaction
fact
autopsi
examin
show
increas
cell
interstitium
lung
patient
diseas
addit
shown
releas
macrophag
epitheli
cell
lung
injuri
effect
synergist
tnfalpha
previous
demonstr
figur
figur
rant
figur
rant
mrna
level
assay
h
h
post
infect
data
shown
result
compar
shown
figur
result
bronchial
epitheli
cell
repres
mean
standard
deviat
three
independ
experi
donor
mean
standard
deviat
result
alveolar
epitheli
cell
base
experi
six
separ
donor
indic
p
compar
mock
indic
p
compar
infect
cell
use
bonferroni
multipl
comparison
test
proinflammatori
cytokin
tnfalpha
hyperinduc
infect
macrophag
therefor
differenti
upregul
express
human
respiratori
epitheli
cell
cytokin
induc
macrophag
virus
may
contribut
synergist
pathogenesi
human
diseas
virus
continu
reassort
acquir
differ
intern
gene
influenza
virus
avian
origin
virus
avietnam
repres
z
genotyp
virus
emerg
domin
viru
genotyp
affect
poultri
southeast
asia
thu
appear
associ
properti
hyperinduc
cytokin
high
virul
addit
pig
epitheli
cell
virus
found
resist
antivir
effect
interferon
may
also
relev
pathogenesi
notabl
patient
avian
influenza
diseas
appear
higher
level
sera
infect
human
influenza
virus
provid
vivo
data
parallel
present
find
vitro
studi
recombin
virus
bear
ha
na
spanish
flu
pandem
viru
show
virus
enhanc
virul
mice
induc
higher
level
macrophagederiv
chemokin
vivo
mice
howev
observ
hyperinduct
cytokin
vivo
may
simpli
reflect
extens
replic
respect
viru
studi
vitro
virus
exclud
potenti
confound
factor
would
relev
studi
cytokin
profil
recombin
virus
vitro
model
similar
describ
subtyp
influenza
virus
associ
human
diseas
potent
human
viru
induc
proinflammatori
cytokin
chemokin
includ
interferon
beta
rant
human
primari
alveolar
bronchial
epitheli
cell
infect
vitro
previou
find
show
virus
also
hyperinduc
cytokin
macrophag
patient
diseas
high
level
chemokin
serum
find
may
relev
pathogenesi
diseas
recent
reemerg
diseas
human
caus
renew
pandem
concern
highlight
need
better
understand
pathogenesi
human
diseas
understand
lead
new
strategi
manag
human
diseas
enhanc
prepared
confront
pandem
influenza
whether
influenza
subtyp
